What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Antibiotics
The scientist’s investigation covers issues in Microbiology, Candida albicans, Biofilm, Pharmacokinetics and Pharmacodynamics.
David R. Andes has researched Microbiology in several fields, including Fungal genetics and In vivo.
His Candida albicans research includes themes of Prospective cohort study, Fungal protein and Gene expression profiling.
His Biofilm research is multidisciplinary, incorporating elements of Extracellular matrix, Cell biology, Cell adhesion and Antifungal.
His work deals with themes such as Streptococcus pneumoniae and Drug, which intersect with Pharmacokinetics.
His Drug study which covers Regimen that intersects with Intensive care medicine.
His most cited work include:
- Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. (2609 citations)
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (1207 citations)
- Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database (966 citations)
What are the main themes of his work throughout his whole career to date?
David R. Andes spends much of his time researching Microbiology, Pharmacodynamics, Candida albicans, Pharmacology and Pharmacokinetics.
David R. Andes has researched Microbiology in several fields, including Staphylococcus aureus, In vivo and Biofilm.
His study looks at the relationship between Pharmacodynamics and topics such as Dosing, which overlap with Intensive care medicine.
The various areas that he examines in his Candida albicans study include Fluconazole, Fungal protein and Cell biology.
His work in Pharmacology covers topics such as Echinocandin which are related to areas like Anidulafungin.
The concepts of his Pharmacokinetics study are interwoven with issues in Minimum inhibitory concentration, Antimicrobial, Antibiotics and Drug.
He most often published in these fields:
- Microbiology (37.93%)
- Pharmacodynamics (26.53%)
- Candida albicans (25.46%)
What were the highlights of his more recent work (between 2016-2021)?
- Pharmacodynamics (26.53%)
- Pharmacology (25.46%)
- Microbiology (37.93%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Pharmacodynamics, Pharmacology, Microbiology, Candida albicans and Pharmacokinetics.
His Pharmacodynamics study combines topics from a wide range of disciplines, such as Antibiotics, Micafungin, Intensive care medicine, Staphylococcus aureus and Dosing.
His Pharmacology research includes themes of Echinocandin and In vivo.
In his research on the topic of Microbiology, Polymyxin and Polymyxin B is strongly related with Pseudomonas aeruginosa.
His studies deal with areas such as Fluconazole, Cell biology and Biofilm as well as Candida albicans.
His Pharmacokinetics study also includes
- Drug that intertwine with fields like Aspergillosis,
- Klebsiella pneumoniae which intersects with area such as Enterobacteriaceae.
Between 2016 and 2021, his most popular works were:
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (285 citations)
- Candida albicans biofilm-induced vesicles confer drug resistance through matrix biogenesis. (73 citations)
- The antimicrobial potential of Streptomyces from insect microbiomes (68 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Bacteria
His scientific interests lie mostly in Pharmacology, Pharmacodynamics, Candida albicans, Pharmacokinetics and Biofilm.
David R. Andes has included themes like Micafungin, Pseudomonas aeruginosa, Cmax, Enterobacteriaceae and Drug in his Pharmacodynamics study.
His work in the fields of Candida albicans, such as Corpus albicans and Candida parapsilosis, intersects with other areas such as Ebselen.
His Pharmacokinetics study integrates concerns from other disciplines, such as Potency, Staphylococcus aureus, In vivo and Liter.
He combines subjects such as Streptococcus mutans, Antifungal drug, High morbidity and Microbiology with his study of Biofilm.
In most of his Microbiology studies, his work intersects topics such as Klebsiella pneumoniae.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
